FDA Grants Fast Track to J&J’s Nipocalimab for Sjö...
Category : ODD/BTA/FTA Status 20 March 2025Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted investiga...
Odd Bta Fta Status
Bayer & Hurdle Announce Major Breakthrough in Agin...
Category : ODD/BTA/FTA Status 17 March 2025Bayer and Hurdle have published groundbreaking research that represents a great advancement in aging...
ClivalLundbeck’s Amlenetug Gains Japanese Orphan D...
Category : ODD/BTA/FTA Status 12 March 2025H. Lundbeck A/S (Lundbeck), a global pharmaceutical company, announced that the Ministry of Health,...
Zydus Lifesciences Unveils Breakthrough Drug for T...
Category : ODD/BTA/FTA Status 8 March 2025Zydus Lifesciences on Wednesday said it has launched ANVIMO, a breakthrough medication for the preve...
FDA & EMA Grant Orphan Drug Status to Bioxodes’ St...
Category : ODD/BTA/FTA Status 7 March 2025Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the preventio...
Latest Newsletter Post
-
AdjuTec Pharma, Venus Remedies Part..
28 March 2025
-
SineuGene Gets FDA Clearance for SN..
28 March 2025
-
Merck Signs $2B Deal with Hengrui P..
28 March 2025
-
United Laboratories, Novo Nordisk S..
27 March 2025
-
Actinium Pharma Partners with Ecker..
27 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com